Published in Pediatr Pulmonol on December 01, 2008
Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci (2010) 1.87
The influence of genetics on cystic fibrosis phenotypes. Cold Spring Harb Perspect Med (2012) 1.07
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun (2010) 1.01
Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatr Pulmonol (2011) 0.98
Genetic influences on cystic fibrosis lung disease severity. Front Pharmacol (2013) 0.88
Disease-modifying genes and monogenic disorders: experience in cystic fibrosis. Appl Clin Genet (2014) 0.88
Generation of Lung Epithelium from Pluripotent Stem Cells. Curr Pathobiol Rep (2013) 0.83
Initial interrogation, confirmation and fine mapping of modifying genes: STAT3, IL1B and IFNGR1 determine cystic fibrosis disease manifestation. Eur J Hum Genet (2011) 0.81
Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia. PLoS One (2014) 0.81
IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability. Hum Genet (2016) 0.79
Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway. Am J Physiol Cell Physiol (2013) 0.78
Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis. Mediators Inflamm (2013) 0.78
Association of transforming growth factor-β1 gene variants with risk of coal workers' pneumoconiosis. J Biomed Res (2010) 0.77
Association between Genetic Variants of Transforming Growth Factor-β1 and Susceptibility of Pneumoconiosis: A Meta-analysis. Chin Med J (Engl) (2017) 0.75
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med (2011) 8.73
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med (2015) 5.51
Presence of the new human metapneumovirus in French children with bronchiolitis. Pediatr Infect Dis J (2003) 3.45
Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J (2013) 3.34
Real-time estimates in early detection of SARS. Emerg Infect Dis (2006) 2.87
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA (2010) 2.75
miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol (2008) 2.61
Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol (2006) 2.49
Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest (2010) 2.29
Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax (2013) 2.20
Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet (2010) 2.12
Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol (2012) 2.08
Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans. Nat Genet (2011) 2.04
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol (2006) 2.01
Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax (2010) 1.97
Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med (2010) 1.94
Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping. J Immunol (2011) 1.89
Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med (2002) 1.87
High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis (2003) 1.84
Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol (2005) 1.83
Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Respir Crit Care Med (2010) 1.82
Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia. J Pediatr (2011) 1.81
Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate. AIDS (2005) 1.80
Noninvasive positive pressure ventilation: five years of experience in a pediatric intensive care unit. Pediatr Crit Care Med (2006) 1.80
Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med (2013) 1.76
Longitudinal decline in lung volume in a population of children with sickle cell disease. Am J Respir Crit Care Med (2008) 1.73
Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat Biotechnol (2012) 1.73
Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res (2011) 1.70
Sputum induction in routine clinical care of children with cystic fibrosis. J Pediatr (2010) 1.67
Effect of dornase alfa on inflammation and lung function: potential role in the early treatment of cystic fibrosis. J Cyst Fibros (2011) 1.65
Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology (2002) 1.62
Impact of changes in serum sodium levels on 2-year neurologic outcomes for very preterm neonates. Pediatrics (2009) 1.59
The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest (2009) 1.56
beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics (2002) 1.54
Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. Eur Respir J (2013) 1.53
Lower airway nitric oxide is increased in children with sickle cell disease. J Pediatr (2011) 1.49
Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One (2011) 1.49
MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease. Hepatology (2014) 1.48
Loss-of-function mutations in LRRC6, a gene essential for proper axonemal assembly of inner and outer dynein arms, cause primary ciliary dyskinesia. Am J Hum Genet (2012) 1.48
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
Subsequent publication of orally presented original studies within 5 years after 1995 RSNA Scientific Assembly. Radiology (2004) 1.40
Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.37
Mortality burden of the 1918-1919 influenza pandemic in Europe. Influenza Other Respir Viruses (2009) 1.35
Human coronavirus NL63, France. Emerg Infect Dis (2005) 1.33
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J (2011) 1.31
Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice. J Physiol (2008) 1.30
Interstitial lung diseases in children. Orphanet J Rare Dis (2010) 1.28
Airway epithelial cell inflammatory signalling in cystic fibrosis. Int J Biochem Cell Biol (2008) 1.26
Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet (2012) 1.26
Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med (2011) 1.25
Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis. J Clin Microbiol (2006) 1.25
Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA (2012) 1.25
Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med (2003) 1.24
Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med (2005) 1.21
Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Mol Cell Biol (2002) 1.20
Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis. Pediatr Pulmonol (2009) 1.19
ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology (2003) 1.18
Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2003) 1.16
miRNA, development and disease. Adv Genet (2012) 1.15
Interacting genetic loci cause airway hyperresponsiveness. Physiol Genomics (2005) 1.15
Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France. J Paediatr Child Health (2007) 1.14
Restoring airway surface liquid in cystic fibrosis. N Engl J Med (2006) 1.14
Inhalation of Moli1901 in patients with cystic fibrosis. Chest (2007) 1.13
Late and ultra late onset Streptococcus B meningitis: clinical and bacteriological data over 6 years in France. Acta Paediatr (2010) 1.13
Colon cancer prognosis prediction by gene expression profiling. Oncogene (2005) 1.13
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Haematologica (2012) 1.13
Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009-2010. PLoS Curr (2010) 1.12
Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum Mol Genet (2011) 1.12
Alveolar inflammation in cystic fibrosis. J Cyst Fibros (2010) 1.11
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. J Clin Oncol (2006) 1.11
NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome". Hum Mutat (2010) 1.11
Laparoscopic resection of hepatocellular carcinoma: a French survey in 351 patients. HPB (Oxford) (2013) 1.10
Therapeutic strategies for idiopathic chylothorax. J Pediatr Surg (2008) 1.09
Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med (2002) 1.09
Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients. J Clin Microbiol (2007) 1.09
Loss-of-function mutations in RSPH1 cause primary ciliary dyskinesia with central-complex and radial-spoke defects. Am J Hum Genet (2013) 1.08
Multiple breath nitrogen washout: a feasible alternative to mass spectrometry. PLoS One (2013) 1.07
Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med (2004) 1.05
Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am J Respir Crit Care Med (2006) 1.05
Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. Pediatr Pulmonol (2008) 1.04
Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLoS One (2009) 1.03
Delineation of CCDC39/CCDC40 mutation spectrum and associated phenotypes in primary ciliary dyskinesia. J Med Genet (2012) 1.02
New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort. Orphanet J Rare Dis (2013) 1.02
Development of a PCR-and hybridization-based assay (PCR Adenovirus Consensus) for the detection and the species identification of adenoviruses in respiratory specimens. J Clin Virol (2004) 1.00
Akt is essential to induce NADPH-dependent NETosis and to switch the neutrophil death to apoptosis. Blood (2014) 1.00
Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol (2007) 1.00